PriceSensitive

Fluence Corporation (ASX:FLC) secures US$250K contract for Aspiral in South Africa

Industrial
ASX:FLC      MCAP $188.3M
07 August 2020 13:00 (AEST)
Fluence Corporation (ASX:FLC) - Transitioning CEO, Henry Charrabé (left)

Source: Perth Now

Fluence Corporation (FLC) has secured a US$250,000 (roughly A$346,978) contract for the first Aspiral system in South Africa.

The Aspiral system includes the MABR (membrane aerated biofilm reactor) wastewater treatment technology.

The Smart Products Solution will be installed by local partner, MEB, and Fluence at one of the wastewater treatment plants in Kwazulu-Natal to process wastewater from effluent to various levels of usage. This will ultimately allow the water to be reused for safe drinking.

The solution will include an Aspiral S1 unit, ultrafiltration and reverse osmosis as well as an optional AOP system and remote supervision.

“Our local and long-term partner MEB, has signed an agreement for a pilot project with eThekwini where the Aspiral system can offer solutions to water-scarce South Africa, alleviating some of the strains on the precious and limited resource in the country,” Fluence Managing Director and CEO Henry Charrabé said.

The company considers this to be a valuable way to demonstrate the benefits of its MABR (membrane aerated biofilm reactor) wastewater treatment technology to potential customers in South Africa.

Fluence claims MABR significantly improves aerobic wastewater treatment because of its efficient nutrient removal and its energy efficiency, compared to traditional wastewater treatment systems.

The first phase of the project is expected to be delivered within eight weeks and installed in the current quarter.

Company shares are trading flat at 18.5 cents each at 12:43 pm AEST.

Related News